# SKAN AG

Source: https://cn.bioecon.ru/companies/skan-ag/
Updated: 2026-08-12

- 国家: Switzerland

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 收购交易通过新的循环信贷额度(RCF)提供资金 | https://ir.skan.com/media/document/613a0a0c-b98e-4b25-a98e-154e791eea4c/assets/SKAN_Annual-Results_FINAL_24032026_a.pdf?disposition=inline |
| 生产基地 | Allschwil（瑞士）、Görlitz（德国）、Gembloux（比利时）、Stein（瑞士） | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://ir.skan.com/media/document/3e14993d-0e1a-4879-ad34-b3751aba0e9d/assets/SKAN_Half_Year_Report_2025.pdf?disposition=inline, https://ir.skan.com/media/document/613a0a0c-b98e-4b25-a98e-154e791eea4c/assets/SKAN_Annual-Results_FINAL_24032026_a.pdf?disposition=inline |
| 认证 | ISO 9001:2015、Great Place to Work认证 | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://skan.com/en/company/about |
| 员工人数 | 1,694（截至2026年6月30日）；1,700（截至2026年2月） | https://skan.com/en/company/about, https://www.eqs-news.com/media/document/ae637cac-1e52-4103-89de-e75be1b88c9a/assets/SKAN_Half_Year_Report_2026.pdf |
| 营收 | CHF 3.333亿(2025财年) | https://stockanalysis.com/quote/swx/SKAN/, https://www.eqs-news.com/news/ad-hoc/skan-mit-gutem-auftragseingang-im-geschaeftsjahr-2025/854d5628-aa02-4d63-8c43-e0fd9c8fd428, https://www.ir.skan.com/en/news/skan-with-good-order-intake-in-the-2025-financial-year/854d5628-aa02-4d63-8c43-e0fd9c8fd428 |
| 监管批准 | 解决方案符合EU-GMP附录1、FDA及ISO标准；采用AT-Closed Vials灌装的个别药品已获得主要监管机构17至19项批准 | https://ir-api.eqs.com/media/document/a5abf301-9a91-468d-ac66-3ca715f03fde/assets/SKAN_Annual_Report_2024.pdf?disposition=inline, https://skan.com/en/company/about, https://www.eqs-news.com/media/document/ae637cac-1e52-4103-89de-e75be1b88c9a/assets/SKAN_Half_Year_Report_2026.pdf |

独立来源: eqs-news.com, ir-api.eqs.com, ir.skan.com, stockanalysis.com

## 技术

- [制药生产用无菌隔离器](https://cn.bioecon.ru/technology/aseptic-isolators-pharma/)